37 Recruiting Advanced Solid Tumor Clinical Trials in California
Explore active advanced solid tumor research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Advanced Solid Tumor Studies in California
A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors
📍 California Clinical Trials Medical Group (CCTMG) — Glendale, California
View Study & Checklist ➔First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer
📍 Providence St. Jude Medical Center — Fullerton, California
View Study & Checklist ➔First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer
📍 Providence St. Jude Medical Center — Fullerton, California
View Study & Checklist ➔Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET
📍 Local Institution - 2102 — La Jolla, California
View Study & Checklist ➔A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
📍 City of Hope At Orange County Lennar Foundation Cancer Center — Irvine, California
View Study & Checklist ➔A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors
📍 Moores Cancer Center, UCSD — La Jolla, California
View Study & Checklist ➔First in Human Study of TORL-3-600 in Participants With Advanced Cancer
📍 Providence Medical Foundation — Fullerton, California
View Study & Checklist ➔A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
📍 Research Site — Palo Alto, California
View Study & Checklist ➔Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors
📍 Sarcoma Oncology Center — Santa Monica, California
View Study & Checklist ➔A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies
📍 Ascendis Pharma Investigational Site — Los Angeles, California
View Study & Checklist ➔Study of CHS-114 in Participants With Advanced Solid Tumors
📍 Stanford Cancer Center — Palo Alto, California
View Study & Checklist ➔Novel mRNA-LNP-Based Intratumoral Immunotherapy in Patients With Advanced Malignant Solid Tumors
📍 IntraAb Inc. — Richmond, California
View Study & Checklist ➔Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
📍 University of California San Diego — La Jolla, California
View Study & Checklist ➔JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
📍 California Cancer Associates for Research and Excellence — Encinitas, California
View Study & Checklist ➔A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
📍 Usc Norris Comprehensive Cancer Center (Nccc) — Los Angeles, California
View Study & Checklist ➔First in Human Study of TORL-1-23 in Participants With Advanced Cancer
📍 Providence Medical Foundation — Fullerton, California
View Study & Checklist ➔A Study of YL201 in Patients With Advanced Solid Tumors
📍 002 — Fair Oaks, California
View Study & Checklist ➔XTX301 in Patients With Advanced Solid Tumors
📍 University of California, Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study of LM-24C5 For Advanced Solid Tumors
📍 University of Southern California (USC) - Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Beta-only IL-2 ImmunoTherapY Study
📍 Sharp Memorial Hospital — San Diego, California
View Study & Checklist ➔Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
📍 University of California, Los Angeles — Santa Monica, California
View Study & Checklist ➔Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
📍 Usc Norris Comprehensive Cancer Center (Nccc) — Los Angeles, California
View Study & Checklist ➔A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors
📍 Scripps Green Hospital — La Jolla, California
View Study & Checklist ➔An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors
📍 Usc Norris Comprehensive Cancer Center (Nccc) — Los Angeles, California
View Study & Checklist ➔Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
📍 # 1019, UCLA, Westwood Cancer Center — Los Angeles, California
View Study & Checklist ➔The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
📍 University of California Irvine Chao Family Comprehensive Cancer Center — Irvine, California
View Study & Checklist ➔A Study of DB-1310 in Advanced/Metastatic Solid Tumors
📍 University of California, Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
📍 Cedars-Sinai Medical Center- Samuel Oschin Comprehensive Cancer Institute — Los Angeles, California
View Study & Checklist ➔A Study of IDP-001 in Advanced or Metastatic Solid Tumors
📍 START Los Angeles — Los Angeles, California
View Study & Checklist ➔A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
📍 University of Southern California — Los Angeles, California
View Study & Checklist ➔A Study of MGC026 in Participants With Advanced Solid Tumors
📍 The Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
📍 Exelixis Clinical Site #12 — Fountain Valley, California
View Study & Checklist ➔Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors
📍 University of California at Davis Cancer Center — Sacramento, California
View Study & Checklist ➔